Traders work on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., July 26, 2016. REUTERS/Brendan McDermid. News and research before you hear about it on CNBC and others.
The third time isn't the charm. Or the fourth. Or the fifth. Or, apparently, the sixth or seventh. Earlier this month, the U.S.
Seres Therapeutics Inc. shares lost three quarters of their value Friday after the biotechnology company said its lead experimental drug failed in a clinical trial testing it against hard-to-treat intestinal infections.
Just two years ago, the sole story of Amazon's second quarter would have been the nearly $900 million in profit that it generated.
Google recently announced its quarterly earnings, and the results are encouraging. The high demand for Google ads, especially on a certain platform, boosted the revenue and profits of the company as well as the value of Alphabet's shares.